Who invested in Complement Therapeutics?
Complement Therapeutics's investors include Forbion Capital Partners.

United Kingdom · Series A startup
Funding summaryUpdated 26 Oct 2026
$79Mraised across 1 round since 2023, from 1 source
Complement Therapeutics's investors include Forbion Capital Partners.
Complement Therapeutics has raised $79M across 1 round since 2023.
Complement Therapeutics's most recent round was a Series A of $79M in Apr 2023.
Its most recent round, $79M in Apr 2023, is also its largest on record.
Complement Therapeutics's first round on record, in Apr 2023, was backed by Forbion Capital Partners.
Complement Therapeutics's latest named round is a Series A, in Apr 2023.
Complement Therapeutics is based in the United Kingdom.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.